Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2026-05-29 16:15:57 ET · period of report 2026-05-28 · accession 0001104659-26-068278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 16:15 | 2026-05-28 | OBIO | Taylor Andrew Lawrence | CFO | F - Tax | $3.98 | -3,076 | 629.4K | -0.5% | -$12.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2026-05-28 | F | D | 3,076 | $3.98 | 629,417 | D | — | — | (F1) Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations. |